Sign inJoin waitlistJoin the waitlist

John Rotrosen

Professor Emeritus of Psychiatry, Department of Psychiatry · NYU Grossman School of Medicine

Credentials: · ·

History

NYU Grossman School of Medicine
Present
NYU Grossman School of Medicine
Present

NYU Grossman School of Medicine
Psychiatry
1978–1982
School of Medicine

Research

Cingulate-precuneus interactions: a new locus of dysfunction in adult attention-deficit/hyperactivity disorder
Biological Psychiatry · 2008 · 661 citations
Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial
The Lancet · 2018 · Last of 23 authors · 560 citations
Misuse and diversion of stimulants prescribed for ADHD: a systematic review of the literature
Systematic review or meta-analysis · Journal of the American Academy of Child & Adolescent Psychiatry · 2008 · 448 citations

BA
Burton Angrist
63 papers · 2 as a resident
Edward Nunes
63 papers
Joshua Lee
37 papers
Lenard Adler
36 papers · 7 as a resident
Adam Wolkin
28 papers · 2 as a resident
EP
Eric Peselow
26 papers
ED
Erica Duncan
25 papers
Matisyahu Shulman
19 papers
MF
Marc Fishman
18 papers
MK
Mary Kreek
14 papers
MS
Michael Serby
13 papers
MA
Miriam Adelson
13 papers

Grants

SOAR: Smartphones for Opioid Addiction Recovery
National Institute on Drug Abuse · R01
PI · $2.2M · New York University School of Medicine
2021–2026
NIDA Clinical Trials Network: New York Node - Renewal-GY24 (CTN-0162)
National Institute on Drug Abuse · UG1
Contact PI · $93.1M · New York University School of Medicine
1999–2025
Computational Neuroeconomic Models of Addiction-Quantifying Progression and Treatment in Opioid Use Disorder
National Institute on Drug Abuse · R01
PI · $2.1M · New York University School of Medicine
2017–2022
Clinical Trials Network: Greater New York Node
National Institute on Drug Abuse · U10
PI · $19.4M · New York State Psychiatric Institute Dba Research Foundation for Mental Hygiene, Inc
2001–2015

Clinical trials

Optimizing Retention, Duration and Discontinuation Strategies for Opioid Use Disorder Pharmacotherapy (RDD)
Principal investigator · Active not recruiting · Phase 2
NYU Langone Health
2021–2027
TAU Opioid Use Outcomes Following Discharge From Detoxification and Short Term Residential Programs Affiliated With CTN-0051
Principal investigator · Completed
NYU Langone Health
2016–2017
Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment
Principal investigator · Completed · Phase 4
NYU Langone Health
2014–2017
Impact of Exercise and Affirmations (IntenSati) on Addiction-related Cognitive and Psychosocial Deficits
Principal investigator · Completed
NYU Langone Health
2010